Eric E Poma
Chief Executive Officer at Calidi Biotherapeutics, Inc. (CLDI) since April 2025
Eric E Poma has filed 11 insider reports with the SEC since February 2021, as chief Executive Officer at Calidi Biotherapeutics, Inc. (CLDI) and officer and director at Molecular Templates, Inc. (MTEM). Eric E Poma made no open-market purchases or sales in the last 12 months. The latest filing, on August 19, 2026, reports grant or award at Calidi Biotherapeutics, Inc. (CLDI).
- Filings
- 11
- Companies
- 2
- Bought on market
- $50K
- Sold on market
- None
Companies where Eric E Poma is an insider
| Company | Role | Shares held | Bought | Sold | Avg buy | Price now | Last filing |
|---|---|---|---|---|---|---|---|
| Chief Executive Officersince April 2025 | 25,000 | $50K | $2.00 | $0.505-75% | Aug 19, 2026 | ||
| Officer, Director | 277,615 | Jan 25, 2024 |
Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.
Every filing
- Aug 17, 2026CLDISEC Form 4 filed by Chief Executive Officer Poma Eric EForm 4Grant or award
- Sep 3, 2025CLDISEC Form 4 filed by Chief Executive Officer Poma Eric EForm 4Grant or award
- Aug 21, 2025+$50KCLDIChief Executive Officer Poma Eric E bought $50,000 worth of shares (25,000 units at $2.00)Form 4Open-market purchase
- Apr 22, 2025CLDISEC Form 4 filed by Chief Executive Officer Poma Eric EForm 4Grant or award
- Apr 22, 2025CLDIEric E Poma became an insiderForm 3New insider
- Jan 23, 2024MTEMSEC Form 4 filed by Poma Eric EForm 4Grant or award
- Feb 15, 2023MTEMSEC Form 4 filed by Poma Eric EForm 4Grant or award
- Apr 27, 2022MTEMSEC Form 4: Poma Eric E exercised 34,156 shares at a strike of $0.71, increasing direct ownership by 14% to 277,615 unitsForm 4Exercise or conversion of a derivative
- Feb 15, 2022MTEMSEC Form 4 filed by Poma Eric EForm 4Grant or award
- Jul 6, 2021MTEMSEC Form 4: Poma Eric E exercised 3,563 units of Common Stock at a strike of $0.71, increasing direct ownership by 1% to 243,459 unitsForm 4Exercise or conversion of a derivative
- Feb 15, 2021MTEMSEC Form 4 filed by E Eric PomaForm 4Grant or award
Also sits on boards with
Officers and directors who share two or more companies with Eric E Poma.
Compare Eric E Poma with
- Eric E Poma vs Sanders Corazon (Corsee) D.2 shared
- Eric E Poma vs Andrew C. Jackson1 shared
- Eric E Poma vs Santidrian Antonio Fernandez1 shared
- Eric E Poma vs James A Schoeneck1 shared
- Eric E Poma vs Scott Leftwich1 shared
- Eric E Poma vs Alan R. Stewart1 shared
Other insiders at the same companies
- Scott LeftwichCLDI
- Alan R. StewartCLDI
- James A SchoeneckCLDI
- George PeoplesCLDI
- Andrew C. JacksonCLDI
- Santidrian Antonio FernandezCLDI
- Allan CamaisaCLDI
- Lincoln Alternative Strategies LLCCLDI
Questions about Eric E Poma
- What is Eric E Poma's role at Calidi Biotherapeutics, Inc.?
- Eric E Poma reports to the SEC as chief Executive Officer at Calidi Biotherapeutics, Inc. (CLDI), according to the latest filing on August 19, 2026. Eric E Poma has also filed as officer and director at Molecular Templates, Inc. (MTEM).
- How many shares does Eric E Poma own?
- After the latest filing that states it, Eric E Poma directly owned 25,000 shares of Calidi Biotherapeutics, Inc. (CLDI) and 277,615 shares of Molecular Templates, Inc. (MTEM). Shares held through trusts, funds or family members are reported separately and are not counted here.
- Has Eric E Poma bought or sold stock recently?
- The most recent open-market purchase was on August 21, 2025: bought 25,000 shares of Calidi Biotherapeutics, Inc. (CLDI) for $50K at an average of $2.00.
- How do I get alerts when Eric E Poma files?
- Follow Eric E Poma on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.
From SEC Forms 3, 4, 5 and 144 filed by Eric E Poma (SEC CIK 0001339484). Totals count each trade once, skipping amendments whose original is on file, from Feb 17, 2021 on. View on SEC EDGAR · Get this as JSON